SI-BONE, Inc. SIBN
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
6/9
Piotroski F — financial health
1.52
Altman Z″ — distress risk · grey
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $200.9M | -$18.9M | $159.9M | -$9.1M | $177.5M |
| 2024 | $167.2M | -$30.9M | $132.1M | -$22.9M | $167.0M |
| 2023 | $138.9M | -$43.3M | $109.4M | -$26.5M | $169.4M |
| 2022 | $106.4M | -$61.3M | $90.7M | -$51.2M | $98.3M |
| 2021 | $90.2M | -$56.6M | $79.7M | -$45.9M | $134.4M |
| 2020 | $73.4M | -$43.7M | $64.5M | -$33.2M | $169.4M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| DUNN JEFFREY W | director | 2026-06-05 | Sell | 3,575 | $15.25 |
| Freund John Gordon | director | 2026-06-04 | Grant | 10,957 | — |
| DUNN JEFFREY W | director | 2026-06-04 | Grant | 10,957 | — |
| West Thomas A. | director | 2026-06-04 | Grant | 10,957 | — |
| HILLEMAN JERYL L | director | 2026-06-04 | Grant | 10,957 | — |
| Davis Timothy E JR | director | 2026-06-04 | Grant | 10,957 | — |
| Nishimura Mika | director | 2026-06-04 | Grant | 10,957 | — |
| Davis Timothy E JR | director | 2026-05-29 | Sell | 3,500 | $14.14 |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.52 (grey)
- Working capital / assets 0.8
- Retained earnings / assets -1.887
- EBIT / assets -0.094
- Equity / liabilities 2.909
Source: SEC EDGAR filings · CIK 0001459839 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.